the recruitment of 60 fatty live men with chronic disease, psoriasis, will be classified to lifestyle modification group (foe 12 weeks, this patients will take supervised energy or diet restriction program plus their usual immunosuppressive drugs ) and control group will continue their drug program only)
Age
18–80
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
psoriasis obese patients with coexisting fatty liver
chronic plaque psoriasis
patients who will not show any change in immuno-modulating psoriasis therapies for at least five months before participation in the study.
